BSECompany Update2d ago · 29 Oct 2026, 05:20 pm
IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer to the Public Shareholders of Kronox Lab Sciences Ltd ("Target Company").
Kronox Lab Sciences Ltd · 544187
✦ AI SummaryFundraise
Kronox Lab Sciences Ltd has received an open offer from Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited to acquire up to 95,70,000 equity shares, representing 25.79% of the voting share capital, at ₹157.27 per share.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kronox Lab Sciences Ltd - 544187 - Letter of Offer
Attachments (1)
📄pdf
Download →
5D036CA9-BCF7-4682-A47C-B969DA1C4ACB-172049.pdf
View document text
October 29, 2026
BSE Limited National Stock Exchange of India Limited
Corporate Relations Exchange Plaza, C-1, Block G,
P. J. Towers, Bandra Kurla Complex,
Dalal Street, Bandra (East),
Mumbai- 400 001 Mumbai – 400 051
Dear Madam / Sir,
Sub.: Open offer by Indo Borax and Chemicals Limited ("Acquirer") along with Zenrock
Chemicals Private Limited ("PAC") to the public shareholders of Kronox Lab Sciences
Limited ("Target Company") for acquisition of equity shares pursuant to Regulations
3(1) and 4 and other applicable provisions of the Securities and Exchange Board of
India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended
("SEBI (SAST) Regulations") ("Offer").
This has reference to the captioned Offer and our letters dated August 20, 2026, August 28, 2026 and
September 4, 2026 for submission of the Public Announcement, Detailed Public Statement and Draft
letter of Offer, respectively.
Please find enclosed copy of the Letter of Offer for your information and records. We have already
emailed soft copy of the Letter of Offer on October 29, 2026.
Thanking you,
Yours faithfully,
For IIFL Capital Services Limited (Formerly known as IIFL Securities Limited)
Name: Yogesh Malpani
Designation: Vice President
Encl: As above
IIFL Capital Services Limited (formerly known IIFL Securities Limited)
Corporate Identity Number: L99999MH1996PLC132983 | SEBI Merchant Banking Registration Number: INM000010940
24th Floor, One Lodha Place, Senapati Bapat Marg, Lower Parel, Mumbai – 400013. Tel: +91 22 4646 4600 Fax: +91 22 2493 1073
Regd. Office: IIFL House, Sun lnfotech Park, Road No. 16V, Plot No. B-23, MIDC, Thane Industrial Area, Wagle Estate, Thane - 400 604
Tel: (91-22) 3929 4000/ 4103 5000 • Fax: (91-22) 2580 6654• E-mail: info.ib@iiflcap.com; secretarial@iifl.com
• Website: www.iiflcap.com; www.iiflcapital.com
LETTER OF OFFER
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION
This Letter of Offer (as defined below) is being sent to you as a Public Shareholders (as defined below ) of Kronox Lab Sciences Limited. If you require any clarifications about the action to be taken,
you may consult your stock broker or investment consultant or the Manager to the Open Offer (as defined below) or Registrar to the Offer (as defined below). In case you have recently sold your
Equity Shares (as defined below) in the Target Company, please hand over this Letter of Offer and the accompanying Form of Acceptance-cum-Acknowledgment (as defined below) and transfer
deed to the member of the stock exchange through whom the said sale was effected.
OPEN OFFER (“OPEN OFFER”/ “OFFER”) BY
INDO BORAX AND CHEMICALS LIMITED (“ACQUIRER”)
A public listed company incorporated under the Companies Act, 1956
Registered Office Address: 506, Tulsiani Chambers, 5th Floor, Nariman Point, Mumbai - 400021, Maharashtra, India;
Corporate Identification Number: L24100MH1980PLC023177
Tel: +91-22-35218591; Email id: info@indoborax.com; Website: www.indoborax.com
Zenrock Chemicals Private Limited (“PAC”)
A private limited company incorporated under the Companies Act, 2013
Registered Office Address: 506, Tulsiani Chambers, Freepress Journal Marg, Nariman Point, Mumbai - 400021, Maharashtra, India;
Corporate Identification Number: U20110MH2025PTC445086
Tel: +91-22-35218591; E-mail id: info@zenrockchemicals.com;
To the Public Shareholder(s) of
KRONOX LAB SCIENCES LIMITED (“TARGET COMPANY”)
A public listed company incorporated under the Companies Act, 1956
Registered Office Address: Block No. 353, Village - Ekalbara, Padra, Vadodara - 391 440, Gujarat, India
Corporate Identification Number: L24117GJ2008PLC055460
Tel: +91 2662 99002; Email id: cs@kronoxlabsciences.com; Website: www.kronoxlabsciences.com
TO ACQUIRE UP TO 95,70,000 (NINETY FIVE LAKHS SEVENTY THOUSAND) FULLY PAID-UP EQUITY SHARES (AS DEFINED
BELOW) OF FACE VALUE ₹10.00 (INDIAN RUPEES TEN ONLY) EACH, REPRESENTING 25.79%* (TWENTY-FIVE POINT SEVEN
NINE PER CENT) OF THE VOTING SHARE CAPITAL (AS DEFINED BELOW) FROM THE PUBLIC SHAREHOLDERS OF THE
TARGET COMPANY AT A PRICE OF ₹157.27 (INDIAN RUPEES ONE HUNDRED FIFTY SEVEN POINT TWO SEVEN ONLY) PER
OFFER SHARE (AS DEFINED BELOW), PAYABLE IN CASH, PURSUANT TO AND IN ACCORDANCE WITH THE SECURITIES AND
EXCHANGE BOARD OF INDIA (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011 AS
AMENDED (“SEBI (SAST) REGULATIONS”)
*As per Regulation 7(1) of the SEBI (SAST) Regulations, the open offer under Regulation 3 and Regulation 4 is required to be made for at least 26.00%
(twenty-six point zero zero per cent) of the total share capital of a target company, as of the 10th working day from the closure of the tendering period
of the open offer. However, the shareholding of the Public Shareholders is only 95,70,000 (ninety five lakhs seventy thousand) Equity Shares
representing 25.79% (twenty five point seven nine per cent) of the Voting Share Capital as of the 10th working day from the closure of the Tendering
Period of the Open Offer, and therefore, the Offer Size represents 25.79% (twenty five point seven nine per cent) of the Voting Share Capital.
1. This Open Offer is being made by the Acquirer along with the PAC (as the ‘person acting in concert’ with the Acquirer) pursuant to and in compliance with the provisions of Regulation
3(1), Regulation 4, and other applicable regulations of the SEBI (SAST) Regulations.
2. The Offer Price is ₹157.27 (Indian Rupees one hundred fifty seven point two seven only) per Equity Share, payable in cash.
3. This Open Offer is not a conditional offer in terms of Regulation 19 of the SEBI (SAST) Regulations and is not subject to any minimum level of acceptance.
4. This Open Offer is not a competing offer in terms of Regulation 20 of the SEBI (SAST) Regulations.
5. As on the date of this Letter of Offer (as defined below), there are no statutory or other approval(s) required by the Acquirer and/or the PAC, to acquire the Equity Shares validly tendered
by Public Shareholders pursuant to this Open Offer and/ or for the Underlying Transaction (as defined below). In case any statutory or other approvals become applicable and are required
by the Acquirer and/or the PAC at a later date before the closure of the Tendering Period (as defined below), this Open Offer shall be subject to receipt of such approval(s).
6. Where any statutory or other approval extends to some but not all the Public Shareholders, the Acquirer shall have the option to make payment to such Public Shareholders in respect of
whom no statutory or other approval(s) are required in order to complete this Open Offer.
7. The marketable lot for the Equity Shares for the purpose of this Offer shall be 1 (one) only.
8. The Acquirer and/or the PAC may withdraw the Open Offer in accordance with the Regulation 23(1) of the SEBI (SAST) Regulations. In the event of a withdrawal of the Open Offer, the
Acquirer and/or the PAC (through the Manager to the Open Offer) shall, within 2 (two) Working Days (as defined below) of such withdrawal, make a public announcement of such
withdrawal, stating the grounds and reasons for the withdrawal, in the same Newspapers (as defined below) in which the Detailed Public Statement (as defined below) was published, in
accordance with Regulation 23(2) of the SEBI (SAST) Regulations and such public announcement will also be sent to SEBI (as defined below), the Stock Exchanges (as defined below)
and the Target Company at its registered office.
9. The Offer Price (as defined below) may be subject to upward revision, if any, pursuant to the SEBI (SAST) Regulations or at the discretion of the Acquirer and/or the PAC at any time
prior to the commencement of the last 1 (one) Working Day before the commencement of the Tendering Period, in accordance with Regulation 18(4) of the SEBI (SAST) Regulations. In
the event of such revision, in terms of Regulation 18(5) of the SEBI (SAST) Regulations, the Acquirer shall: (i) make corresponding increase to the Escrow Amoun
[Showing first 8,000 characters — download PDF for full document]